Home ›
Trademark Categories ›
Pharmaceuticals ›
2006 ›
IC ›
ICOZZIR
Trademark search for:
ICOZZIR
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2006-02-21 — Application filed
2006-02-28 — Application filed
2006-07-13 — Assigned to examiner
2006-07-21 — Final disposition recorded
2006-07-21 — Final disposition recorded
2006-08-21 — Paper received
2006-08-21 — Correspondence received in law office
2006-08-25 — Amendment from applicant entered
2006-09-14 — Suspension letter written
2006-09-14 — Letter of suspension e-mailed
2007-04-02 — Assigned to lie
2007-04-02 — Suspension checked - to attorney for action
2007-04-20 — Report completed suspension check case still suspended
2007-07-23 — Attorney/dom.rep.revoked and/or appointed
2007-07-23 — Teas revoke/app/change addr of atty/dom rep received
2007-11-05 — Report completed suspension check case still suspended
2008-05-06 — Report completed suspension check case still suspended
2008-11-20 — Report completed suspension check case still suspended
2009-05-29 — Report completed suspension check case still suspended
2009-12-02 — Suspension checked - to attorney for action
2009-12-23 — Approved for pub - principal register
2009-12-26 — Law office publication review completed
2010-02-02 — Published for opposition
2010-02-02 — Official gazette publication confirmation e-mailed
2010-03-02 — Extension of time to oppose received
2010-08-17 — Extension of time to oppose process - terminated
2010-09-28 — Noa e-mailed - sou required from applicant
2011-05-02 — Application abandoned
2011-05-02 — Application abandoned
2011-05-02 — Final status recorded
Owner Information
AstraZeneca AB
Sodertalje SE
AstraZeneca AB
Sodertalje SE
Correspondent
Wm. Charles Saunders AstraZeneca Pharmaceuticals LP 1800 Concord Pike OW2 Wilmington, DE 19850
Filing Details
Filing Date:
2006-02-21
Status Date:
2011-05-02
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.